A four-point clinical criteria distinguishes immune thrombocytopenia from acute lymphoblastic leukaemia

Area of Science:

• Pediatrics
• Hematology
• Oncology

Background:

• Isolated thrombocytopenia in children presents a diagnostic challenge, with a risk of misdiagnosing acute leukemia.
• Immune thrombocytopenia (ITP) is the most frequent cause of isolated thrombocytopenia in pediatric patients.

Purpose of the Study:

• To establish reliable clinical criteria for diagnosing childhood ITP.
• To determine if bone marrow examination is essential for diagnosing ITP in children before initiating steroid therapy.
• To facilitate the use of steroid therapy as a first-line treatment for children with significant bleeding due to ITP.

Main Methods:

• Development and application of a four-point clinical diagnostic criteria for childhood ITP.
• Retrospective analysis of clinical data to validate the diagnostic criteria.
• Comparison of diagnostic accuracy with and without bone marrow examination.

Main Results:

• A four-point clinical criteria effectively diagnosed childhood ITP.
• The proposed criteria successfully differentiated ITP from acute leukemia, eliminating the need for bone marrow examination in typical cases.
• Steroid therapy was identified as a safe and effective first-line treatment for children with significant hemorrhage.

Conclusions:

• A four-point clinical assessment is sufficient for diagnosing childhood ITP, obviating the need for bone marrow biopsy in most cases.
• This diagnostic approach supports the use of steroid therapy as an accessible and cost-effective first-line treatment for pediatric ITP with bleeding.
• Accurate and timely diagnosis of ITP can prevent delays in appropriate treatment and reduce healthcare costs.